Comparative Study of the Quality of Life of Patients With Ototoxicity Due to Platinum-Based Chemotherapy, With Hearing Aid Versus Those Without: Study Protocol for a Randomized Pilot Study-The PROTOTOX Study.

Fiche publication

Date publication

octobre 2025

Journal

JMIR research protocols

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DOLIVET Gilles , Dr MASTRONICOLA Romina

Tous les auteurs :
Mastronicola R, Kayser E, Fernandez Y, Dolivet G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41071987

Résumé

Platinum salts are widely used for the treatment of cancers, including head and neck cancers. Despite their efficacy, platinum salts can induce neurosensory disorders such as ototoxicity, tinnitus, and decreased hearing acuity. These side effects can have a major impact on the quality of life of patients and are not often considered after treatment.